Cargando…
The prevalence of hyperuricemia in China: a meta-analysis
BACKGROUND: The prevalence of hyperuricemia varied in different populations and it appeared to be increasing in the past decades. Recent studies suggest that hyperuricemia is an independent risk factor for cardiovascular disease. However, there has not yet been a systematic analysis of the prevalenc...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213156/ https://www.ncbi.nlm.nih.gov/pubmed/22032610 http://dx.doi.org/10.1186/1471-2458-11-832 |
_version_ | 1782216091341160448 |
---|---|
author | B, Liu T, Wang HN, Zhao WW, Yue HP, Yu CX, Liu J, Yin RY, Jia HW, Nie |
author_facet | B, Liu T, Wang HN, Zhao WW, Yue HP, Yu CX, Liu J, Yin RY, Jia HW, Nie |
author_sort | B, Liu |
collection | PubMed |
description | BACKGROUND: The prevalence of hyperuricemia varied in different populations and it appeared to be increasing in the past decades. Recent studies suggest that hyperuricemia is an independent risk factor for cardiovascular disease. However, there has not yet been a systematic analysis of the prevalence of hyperuricemia in China. METHODS: Epidemiological investigations on hyperuricemia in China published in journals were identified manually and on-line by using CBMDISC, Chongqing VIP database and CNKI database. Those Reported in English journals were identified using MEDLINE database. Selected studies had to describe an original study defined by strict screening and diagnostic criteria. The fixed effects model or random effects model was employed according to statistical test for homogeneity. RESULTS: Fifty-nine studies were selected, the statistical information of which was collected for systematic analysis. The results showed that the pooled prevalence of hyperuricemia in male was 21.6% (95%CI: 18.9%-24.6%), but it was only 8.6% (95%CI: 8.2%-10.2%) in female. It was found that thirty years was the risk point age in male and it was fifty years in female. CONCLUSIONS: The prevalence of hyperuricemia is different as the period of age and it increases after 30 years in male and 50 in female. Interventions are necessary to change the risk factors before the key age which is 30 years in male and 50 in female. |
format | Online Article Text |
id | pubmed-3213156 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32131562011-11-11 The prevalence of hyperuricemia in China: a meta-analysis B, Liu T, Wang HN, Zhao WW, Yue HP, Yu CX, Liu J, Yin RY, Jia HW, Nie BMC Public Health Research Article BACKGROUND: The prevalence of hyperuricemia varied in different populations and it appeared to be increasing in the past decades. Recent studies suggest that hyperuricemia is an independent risk factor for cardiovascular disease. However, there has not yet been a systematic analysis of the prevalence of hyperuricemia in China. METHODS: Epidemiological investigations on hyperuricemia in China published in journals were identified manually and on-line by using CBMDISC, Chongqing VIP database and CNKI database. Those Reported in English journals were identified using MEDLINE database. Selected studies had to describe an original study defined by strict screening and diagnostic criteria. The fixed effects model or random effects model was employed according to statistical test for homogeneity. RESULTS: Fifty-nine studies were selected, the statistical information of which was collected for systematic analysis. The results showed that the pooled prevalence of hyperuricemia in male was 21.6% (95%CI: 18.9%-24.6%), but it was only 8.6% (95%CI: 8.2%-10.2%) in female. It was found that thirty years was the risk point age in male and it was fifty years in female. CONCLUSIONS: The prevalence of hyperuricemia is different as the period of age and it increases after 30 years in male and 50 in female. Interventions are necessary to change the risk factors before the key age which is 30 years in male and 50 in female. BioMed Central 2011-10-27 /pmc/articles/PMC3213156/ /pubmed/22032610 http://dx.doi.org/10.1186/1471-2458-11-832 Text en Copyright ©2011 B et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article B, Liu T, Wang HN, Zhao WW, Yue HP, Yu CX, Liu J, Yin RY, Jia HW, Nie The prevalence of hyperuricemia in China: a meta-analysis |
title | The prevalence of hyperuricemia in China: a meta-analysis |
title_full | The prevalence of hyperuricemia in China: a meta-analysis |
title_fullStr | The prevalence of hyperuricemia in China: a meta-analysis |
title_full_unstemmed | The prevalence of hyperuricemia in China: a meta-analysis |
title_short | The prevalence of hyperuricemia in China: a meta-analysis |
title_sort | prevalence of hyperuricemia in china: a meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213156/ https://www.ncbi.nlm.nih.gov/pubmed/22032610 http://dx.doi.org/10.1186/1471-2458-11-832 |
work_keys_str_mv | AT bliu theprevalenceofhyperuricemiainchinaametaanalysis AT twang theprevalenceofhyperuricemiainchinaametaanalysis AT hnzhao theprevalenceofhyperuricemiainchinaametaanalysis AT wwyue theprevalenceofhyperuricemiainchinaametaanalysis AT hpyu theprevalenceofhyperuricemiainchinaametaanalysis AT cxliu theprevalenceofhyperuricemiainchinaametaanalysis AT jyin theprevalenceofhyperuricemiainchinaametaanalysis AT ryjia theprevalenceofhyperuricemiainchinaametaanalysis AT hwnie theprevalenceofhyperuricemiainchinaametaanalysis AT bliu prevalenceofhyperuricemiainchinaametaanalysis AT twang prevalenceofhyperuricemiainchinaametaanalysis AT hnzhao prevalenceofhyperuricemiainchinaametaanalysis AT wwyue prevalenceofhyperuricemiainchinaametaanalysis AT hpyu prevalenceofhyperuricemiainchinaametaanalysis AT cxliu prevalenceofhyperuricemiainchinaametaanalysis AT jyin prevalenceofhyperuricemiainchinaametaanalysis AT ryjia prevalenceofhyperuricemiainchinaametaanalysis AT hwnie prevalenceofhyperuricemiainchinaametaanalysis |